Overview
A tryptophan hydroxylase inhibitor. Telotristat ethyl (brand name Xermelo) is a prodrug of telotristat.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/12/17 | Phase 2 | Withdrawn | |||
2020/09/10 | Phase 2 | Terminated | Lowell Anthony, MD | ||
2018/03/05 | Phase 2 | Completed | |||
2018/02/22 | Phase 1 | Completed | |||
2017/10/05 | Phase 1 | Completed | |||
2017/07/21 | N/A | Completed | |||
2016/02/17 | Phase 1 | Completed | |||
2014/07/21 | Phase 1 | Completed | |||
2014/06/06 | Phase 1 | Completed | |||
2014/06/06 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 9/17/2017 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| XERMELO telotristat ethyl (as telotristat etiprate) 250 mg film-coated tablet blister pack | 291734 | Medicine | A | 9/14/2018 |
Help Us Improve
Your feedback helps us provide better drug information and insights.